Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/000534 stock hub

SHE/000534 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/000534is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
19B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/000534
In the news

Latest news · SHE/000534

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E70.4
P25 17.1P50 24.2P75 37.8
Trailing P/E99.2
P25 23.5P50 41.3P75 83.2
ROE9.7
P25 -0.9P50 4.1P75 8.8
ROIC4.2
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/000534 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
225
Groups with data
11
Currency
CNY
Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
1,397
Employees Change
7%
Employees Change Percent
0.5
Enterprise value
CNY 20.9B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CNE0000004T4
Last refreshed
2026-05-10
Market cap
CNY 19B
Price
CNY 39.4
Price currency
CNY
Rev Per Employee
941,479.03x
Sector
Healthcare
Sic
6500
Symbol
she/000534
Website
https://www.wedgeind.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
1.06%
EV Earnings
103.61x
EV/EBIT
79.58x
EV/EBITDA
58.26x
EV/FCF
-72.13x
EV/Sales
15.9x
FCF yield
-1.53%
Forward P/E
70.36x
P/B ratio
9.92x
P/E ratio
99.18x
P/S ratio
14.45x
PE Ratio10 Y
67.59x
PE Ratio3 Y
43.59x
PE Ratio5 Y
55.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
19.97%
EBITDA Margin
26.91%
Gross margin
70.62%
Gross Profit
CNY 928.8M
Net Income
CNY 201.8M
Net Income Growth
1.07%
Net Income Growth Q
6.58%
Net Income Growth Quarters
1%
Net Income Growth Years
6%
Net Income Growth3 Y
16.51%
Net Income Growth5 Y
21.68%
Pretax Margin
15.04%
Profit Margin
15.34%
Profit Per Employee
CNY 144,451
Profitable Years
34
ROA
3.47
Roa5y
3.29
ROCE
6.48
ROE
9.68
Roe5y
11.13
ROIC
4.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

24
MetricValue
Cagr10y
12.6%
Cagr15y
13.85%
Cagr1y
153.14%
Cagr20y
16.51%
Cagr3y
33.15%
Cagr5y
24.82%
Div CAGR10
0%
Div CAGR3
0%
Div CAGR5
-3.58%
EPS Growth
1.3
EPS Growth Q
5.63
EPS Growth Quarters
1
EPS Growth Years
6
EPS Growth3 Y
16.43
EPS Growth5 Y
20.9
OCF Growth
3.32%
OCF Growth3 Y
-25.87%
OCF Growth5 Y
6.21%
Revenue Growth
17.08x
Revenue Growth Q
7.39x
Revenue Growth Quarters
11x
Revenue Growth Years
6x
Revenue Growth3 Y
11.89x
Revenue Growth5 Y
20.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
CNY 0.28
Assets
CNY 5.4B
Cash
CNY 849.9M
Current Assets
CNY 2.1B
Current Liabilities
CNY 1.3B
Debt
CNY 2.6B
Debt EBITDA
CNY 7.12
Debt Equity
CNY 1.33
Debt FCF
CNY -8.81
Equity
CNY 1.9B
Liabilities
CNY 3.5B
Long Term Assets
CNY 3.2B
Long Term Liabilities
CNY 2.1B
Net Cash
CNY -1.7B
Net Cash By Market Cap
CNY -8.97
Net Debt EBITDA
CNY 4.82
Net Debt Equity
CNY 0.89
Tangible Book Value
CNY 1.3B
Tangible Book Value Per Share
CNY 2.66
WACC
6.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.61
Inventory Turnover
0.92
Net Working Capital
CNY 705.9M
Quick ratio
1.18
Working Capital
CNY 808.8M
Working Capital Turnover
CNY 2.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
0.23%
Dividend Growth
-58.33%
Dividend Growth Years
0%
Dividend per share
CNY 0.05
Dividend Years
18
Dividend Yield
0.13%
Ex Div Date
2025-08-14
Last Dividend
CNY 0.05
Payout Frequency
Annual
Payout Ratio
49.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
227.45%
1Y total return
152.98%
200-day SMA
25.04
3Y total return
136.08%
50-day SMA
40.74
50-day SMA vs 200-day SMA
50over200
5Y total return
202.88%
All Time High
49.14
All Time High Change
-19.82%
All Time High Date
2026-03-10
All Time Low
1.15
All Time Low Change
3,320.14%
All Time Low Date
1996-02-06
ATR
3.36
Beta
0.58
Beta1y
1.11
Beta2y
1.09
Ch YTD
79.09
High
41.61
High52
49.14
High52 Date
2026-03-10
High52ch
-19.82%
Low
39.3
Low52
12.91
Low52 Date
2025-06-23
Low52ch
205.19%
Ma50ch
-3.3%
Price vs 200-day SMA
57.35%
RSI
46.6
RSI Monthly
74.35
RSI Weekly
62.03
Sharpe ratio
1.78x
Sortino ratio
3.15
Total Return
0.36%
Tr YTD
79.09
Tr15y
599.57%
Tr1m
10.21%
Tr1w
-3.43%
Tr3m
35.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CNY 262.6M
Operating margin
19.97

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
332,619,204%
Net Borrowing
865,717,742
Shares Insiders
3.4%
Shares Institutions
17.48%
Shares Out
482,352,359
Shares Qo Q
0.61%
Shares Yo Y
-0.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
CNY -289.9M
Average Volume
27,488,063.2x
Bv Per Share
3.4
CAPEX
CNY -400.3M
Ch10y
212
Ch15y
535.5
Ch1m
10.21
Ch1w
-3.43
Ch1y
152.2
Ch20y
1,736.8
Ch3m
35.63
Ch3y
131.4
Ch5y
194.7
Ch6m
75.03
Change
-7.99%
Change From Open
-5.11
Close
42.82
Days Gap
-3.04
Dollar Volume
1,217,336,717.4
Earnings Date
2026-04-21
EBIT
CNY 262.6M
EBITDA
CNY 353.9M
EPS
CNY 0.4
F Score
4
FCF
CNY -289.9M
FCF EV Yield
-1.39x
FCF Per Share
CNY -0.6
Financing CF
841,652,418
Fiscal Year End
December
Founded
1,992
Graham Number
5.51356
Graham Upside
-86.01
Income Tax
CNY 23.9M
Investing CF
-371,433,728
Is Primary Listing
1
Last Earnings Date
2026-04-21
Last Report Date
2026-03-31
Last Split Date
2006-08-11
Last Split Type
Forward
Lynch Fair Value
CNY 8.61
Lynch Upside
-78.14
Ma150
28.08
Ma150ch
40.32%
Ma20
42.34
Ma20ch
-6.95%
Net CF
580,621,257
Next Earnings Date
2026-08-28
Open
41.52
P OCF Ratio
172
Payment Date
2025-08-14
Position In Range
4.33
Ppne
2,262,712,925
Price Date
2026-05-08
Price EBITDA
CNY 53.7
Ptbv Ratio
14.14
Relative Volume
1.13x
Revenue
1,315,246,208x
Tax By Revenue
1.81x
Tax Rate
12.06%
Tr20y
2,026.12%
Tr6m
75.03%
Volume
30,896,871
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/000534 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.1%
$0.05 annual per share
Payout ratio
+49.0%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-3.6%
0 consecutive years of growth
Total shareholder yield
+0.4%
Next ex-dividend date: 2025-08-14
Performance

SHE/000534 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+153.0%
S&P 500 1Y: n/a
3Y total return
+136.1%
S&P 500 3Y: n/a
5Y total return
+202.9%
S&P 500 5Y: n/a
10Y total return
+227.4%
S&P 500 10Y: n/a
Ownership

Who owns SHE/000534?

Insider, institutional, and short-interest positioning.

Institutional ownership
+17.5%
Share of float held by funds and institutions
Insider ownership
+3.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.2%
Negative means the company is buying back shares.
Technical

SHE/000534 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.6
Neutral momentum band
Price vs 200-day MA
+57.3%
50/200-day relationship not available
Beta (5Y)
0.58
Less volatile than the market
Sharpe ratio
1.78
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/000534

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/000534 stock rating?

she/000534 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/000534 analysis?

The full report lives at /stocks/she/000534/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/000534?

The latest report frames she/000534 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/000534 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

she/000534 stock profile: metrics, valuation and analysis | StockMarketAgent.AI